Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goldhirsch

Showing results (271-280 of 753) with videos related to

Pageof 76
Sort By:
Breast Cancer Research : BCR|November 24, 2007
International Web-based consultation on priorities for translational breast cancer researchMitch Dowsett, Aron Goldhirsch, Daniel F Hayes, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1984
Receptor heterogeneity of human breast cancer as measured by multiple intratumoral assays of estrogen and progesterone receptorB W Davis, D T Zava, G W Locher, et al.
Breast Cancer Research and Treatment|October 14, 2016
Time to incorporate germline multigene panel testing into breast and ovarian cancer patient careRossella Graffeo, Luca Livraghi, Olivia Pagani, et al.
Journal of Palliative Medicine|March 6, 2004
Integrating case management and palliative careDiane E Meier, William Thar, Ashby Jordan, et al.
Deutsche Medizinische Wochenschrift (1946)|August 28, 1981
[Etoposide. A new highly effective cytostatic agent in anaplastic small-cell bronchial carcinoma, other solid tumors and hemoblastoses]A Goldhirsch, R Joss, F Cavalli, et al.
Cancer Treatment Reports|February 1, 1980
Combination chemotherapy with VM-26, adriamycin bleomycin, and prednisone as a secondary treatment of malignant lymphomaA Goldhirsch, M Pirovino, R W Sonntag, et al.
American Journal of Clinical Oncology|October 1, 1982
An evaluation of tamoxifen dose escalation in advanced breast cancerA Goldhirsch, R A Joss, U Leuenberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group studyB F Cole, R D Gelber, J M Kirkwood, et al.
Lancet (London, England)|July 31, 1993
Premenopausal oopherectomy versus CMF chemotherapy in stage II breast carcinoma. The International Breast Cancer Study Group (IBCSG)R D Gelber, A Goldhirsch, M Castiglione, et al.
Breast Cancer Research and Treatment|August 27, 2010
The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, ItalyGabriel Farante, Stefano Zurrida, Viviana Galimberti, et al.
Pageof 76

Showing results (271-280 of 753) with videos related to

Sort By:
Pageof 76
Breast Cancer Research : BCR|November 24, 2007
International Web-based consultation on priorities for translational breast cancer researchMitch Dowsett, Aron Goldhirsch, Daniel F Hayes, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1984
Receptor heterogeneity of human breast cancer as measured by multiple intratumoral assays of estrogen and progesterone receptorB W Davis, D T Zava, G W Locher, et al.
Breast Cancer Research and Treatment|October 14, 2016
Time to incorporate germline multigene panel testing into breast and ovarian cancer patient careRossella Graffeo, Luca Livraghi, Olivia Pagani, et al.
Journal of Palliative Medicine|March 6, 2004
Integrating case management and palliative careDiane E Meier, William Thar, Ashby Jordan, et al.
Deutsche Medizinische Wochenschrift (1946)|August 28, 1981
[Etoposide. A new highly effective cytostatic agent in anaplastic small-cell bronchial carcinoma, other solid tumors and hemoblastoses]A Goldhirsch, R Joss, F Cavalli, et al.
Cancer Treatment Reports|February 1, 1980
Combination chemotherapy with VM-26, adriamycin bleomycin, and prednisone as a secondary treatment of malignant lymphomaA Goldhirsch, M Pirovino, R W Sonntag, et al.
American Journal of Clinical Oncology|October 1, 1982
An evaluation of tamoxifen dose escalation in advanced breast cancerA Goldhirsch, R A Joss, U Leuenberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group studyB F Cole, R D Gelber, J M Kirkwood, et al.
Lancet (London, England)|July 31, 1993
Premenopausal oopherectomy versus CMF chemotherapy in stage II breast carcinoma. The International Breast Cancer Study Group (IBCSG)R D Gelber, A Goldhirsch, M Castiglione, et al.
Breast Cancer Research and Treatment|August 27, 2010
The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, ItalyGabriel Farante, Stefano Zurrida, Viviana Galimberti, et al.
Pageof 76